180 related articles for article (PubMed ID: 27431884)
1. Palmoplantar pustulosis by adalimumab in a patient with Crohn disease.
Ortiz Salvador JM; Cubells Sánchez L; Subiabre Ferrer D
Med Clin (Barc); 2016 Dec; 147(12):565. PubMed ID: 27431884
[No Abstract] [Full Text] [Related]
2. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
[No Abstract] [Full Text] [Related]
3. Adalimumab-induced psoriasis in a patient with Crohn's disease.
Korkmaz U; Duman AE; Dindar G; Yilmaz H; Dursun IH; Celebi A; Senturk O; Hulagu S
Indian J Gastroenterol; 2013 Mar; 32(2):135-6. PubMed ID: 23151897
[No Abstract] [Full Text] [Related]
4. Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.
Mishra V; Daniel RC; Elmets CA; Levin A; Elewski BE
J Drugs Dermatol; 2013 Jan; 12(1):16-7. PubMed ID: 23377322
[No Abstract] [Full Text] [Related]
5. Adalimumab-induced porokeratosis.
Frew JW; Parsi K
Australas J Dermatol; 2015 Aug; 56(3):e80-1. PubMed ID: 26201378
[No Abstract] [Full Text] [Related]
6. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
7. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
[TBL] [Abstract][Full Text] [Related]
8. Case of psoriasiform and pustular eruptions in addition to alopecia as a paradoxical reaction induced by infliximab.
Shimokata M; Namiki T; Tokoro S; Ugajin T; Miura K; Yokozeki H
J Dermatol; 2018 Dec; 45(12):e331-e333. PubMed ID: 29855072
[No Abstract] [Full Text] [Related]
9. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
[No Abstract] [Full Text] [Related]
10. Mediterranean spotted fever in a patient with Crohn's disease under adalimumab: First case report and review of the literature.
Santos-Antunes J; Nunes AC; Macedo G
Gastroenterol Hepatol; 2015; 38(6):379-80. PubMed ID: 25073681
[No Abstract] [Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab.
Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ
Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973
[No Abstract] [Full Text] [Related]
12. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
13. Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.
Hunt WTN; Wheeler JF; Kennedy NA; Burden T; McGrath EJ
Clin Exp Dermatol; 2021 Jan; 46(1):216-218. PubMed ID: 32931629
[No Abstract] [Full Text] [Related]
14. Adalimumab-induced scalp psoriasis with severe alopecia.
Özkur E; Altunay İK; Leblebici C; Topkarcı Z; Erdem Y
Dermatol Ther; 2019 Sep; 32(5):e13033. PubMed ID: 31350777
[TBL] [Abstract][Full Text] [Related]
15. Education and imaging. Gastrointestinal: Cutaneous reaction associated with loss of response to adalimumab.
Hillemand CG; Leong RW
J Gastroenterol Hepatol; 2013 Jul; 28(7):1073. PubMed ID: 23782119
[No Abstract] [Full Text] [Related]
16. IgA nephropathy onset in a Crohn's disease patient treated with Adalimumab.
Bruzzese V; Lorenzetti R; Rosa M; Di Giulio S; Hassan C; Costas G; Zullo A
Minerva Gastroenterol Dietol; 2016 Jun; 62(2):223-4. PubMed ID: 27091038
[No Abstract] [Full Text] [Related]
17. Psoriasiform Eruption Secondary to the Use of Adalimumab.
Esteves PM; Barbalho MG; Cortes JG; Cuzzi T; Sodre CT; Ramos-e-Silva M
J Drugs Dermatol; 2015 Oct; 14(10):1152-4. PubMed ID: 26461828
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
Ferrer Bradley I; Maroto Arce N; Mora Escrig M; Hinojosa Del Val J
Gastroenterol Hepatol; 2019; 42(6):387-388. PubMed ID: 30042000
[No Abstract] [Full Text] [Related]
19. First case report of adalimumab-induced psoriasis in Crohn's disease.
Harris MD; Richards R
Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
[No Abstract] [Full Text] [Related]
20. Acneiform eruption as a probable paradoxical reaction to adalimumab.
Fernández-Crehuet P; Ruiz-Villaverde R
Int J Dermatol; 2015 Aug; 54(8):e306-8. PubMed ID: 24697221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
